NeoTract, Inc.'s Minimally Invasive UroLift System For Enlarged Prostate Now Shown To Be Durable Through Five Years: Results From Pivotal L.I.F.T. Randomized Study Presented Post author:Sam Post published:March 26, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Teva's Job Cuts Hit 208 Philadelphia Employees January 18, 2018 Neurocrine Biosciences Announces Publication Of Positive Results From Kinect 3 Phase III Study Of INGREZZA TM (Valbenazine) For The Treatment Of Tardive Dyskinesia March 20, 2017 BioMarin Shoots Up on Roche Takeover Rumor July 8, 2016
Neurocrine Biosciences Announces Publication Of Positive Results From Kinect 3 Phase III Study Of INGREZZA TM (Valbenazine) For The Treatment Of Tardive Dyskinesia March 20, 2017